Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease

American Heart Journal

Volumn 162, Issue 5, 2011, Pages

  Zacharski, Leo R ^a,b   Shamayeva, Galina ^c   Chow, Bruce K ^c  

^a Research Service (151)   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FERRITIN BLOOD LEVEL; HEART INFARCTION; HUMAN; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHLEBOTOMY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STROKE;

EID: 81255201423     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.08.013     Document Type: Article

References (39)

1. J.L. Sullivan Iron and sex difference in heart disease risk Lancet 1 1981 1293 1294 (Pubitemid 11111356)
2. L.R. Zacharski, D.L. Ornstein, and S. Woloshin Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data Am Heart J 140 2000 98 104 (Pubitemid 30471247)
3. C.W. Levenson, and N.M. Tassabehji Iron and ageing: an introduction to iron regulatory mechanisms Ageing Res Rev 3 2004 251 263 (Pubitemid 38844695)
4. K.F. Gey Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease Br Med Bull 49 1993 679 699 (Pubitemid 23243839)
5. L.R. Zacharski, B. Chow, and P.W. Lavori The Iron (Fe) and Atherosclerosis Study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease Am Heart J 139 2000 337 345 (Pubitemid 30090812)
6. L.R. Zacharski, B.K. Chow, and P.S. Howes Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease JAMA 297 2007 603 610
7. L.R. Zacharski, B.K. Chow, and P.S. Howes Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST) Am Heart J 148 2004 386 392 (Pubitemid 39265109)
8. L.R. Zacharski, B.K. Chow, and P.S. Howes Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial J Natl Cancer Inst 100 2008 996 1002 (Pubitemid 352019800)
9. B. Buijsse, E.J. Feskens, and J. Moschandreas Oxidative stress, and iron and antioxidant status in elderly men: differences between the Mediterranean south (Crete) and northern Europe (Zutphen) Eur J Cardiovasc Prev Rehabil 14 2007 495 500 (Pubitemid 47229728)
10. D.J. Fleming, K.L. Tucker, and P.F. Jacques Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort Am J Clin Nutr 76 2002 1375 1384 (Pubitemid 35416575)
11. S. Kiechl, J. Willeit, and G. Egger Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study Circulation 96 1997 3300 3307 (Pubitemid 27513398)
12. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
13. D.R. Cox Regression models and life-tables J R Stat Soc [B] 34 1972 187 220
14. A.D.L. van der, P.H. Peeters, and D.E. Grobbee HFE mutations and risk of coronary heart disease in middle-aged women Eur J Clin Invest 36 2006 682 690 (Pubitemid 44393926)
15. J.L. Sullivan Do hemochromatosis mutations protect against iron-mediated atherogenesis? Circ Cardiovasc Genet 2 2009 652 657
16. P.J. Kraml, R.L. Klein, and Y. Huang Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes Metabolism 54 2005 453 459 (Pubitemid 40410444)
17. A. Daugherty, D.L. Rateri, and H. Lu As macrophages indulge, atherosclerotic lesions bulge Circ Res 102 2008 1445 1447
18. C. Ellervik, A. Tybjaerg-Hansen, and M. Appleyard Hereditary hemochromatosis genotypes and risk of ischemic stroke Neurology 68 2007 1025 1031 (Pubitemid 46569137)
19. T. Dunn, D. Blankenship, and N. Beal HFE mutations in heart disease Heart Vessels 23 2008 348 355 [Epub 2008, Sep 20]
20. H. Gaenzer, P. Marschang, and W. Sturm Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis J Am Coll Cardiol 40 2002 2189 2194 (Pubitemid 36005907)
21. J.B. Muhlestein Cardiac abnormalities in hemochromatosis J.C. Barton, C.Q. Edwards, Hemochromatosis: genetics, pathophysiology, diagnosis and treatment 2000 Cambridge University Press Cambridge 297 311
22. Q. Sun, J. Ma, and N. Rifai Excessive body iron stores are not associated with risk of coronary heart disease in women J Nutr 138 2008 2436 2441
23. Menke A, Muntner P, Fernández-Real JM, et al. The association of biomarkers of iron status with mortality in US adults. Nutr Metab Cardiovasc Dis. Epub 2011, Feb 15.
24. J.L. Sullivan Misconceptions in the debate on the iron hypothesis J Nutr Biochem 12 2001 33 37 (Pubitemid 32120194)
25. J. Steffel, and T.F. Lüscher Predicting the development of atherosclerosis Circulation 119 2009 919 921
26. H. Zheng, R. Cable, and B. Spencer Iron stores and vascular function in voluntary blood donors Arterioscler Thromb Vasc Biol 25 2005 1577 1583 (Pubitemid 41098924)
27. D.G. Meyers, K.C. Jensen, and J.E. Menitove A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events Transfusion 42 2002 1135 1139
28. I.S. Fraser, P. Warner, and P.A. Marantos Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume Obstet Gynecol 98 2001 806 814 (Pubitemid 33042549)
29. G.J. Murphy, B.C. Reeves, and C.A. Rogers Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery Circulation 116 2007 2544 2552 (Pubitemid 350179219)
30. S.M. Jani, D.E. Smith, and D. Share Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention Clin Cardiol 30 10 Suppl 2 2007 1149 1156
31. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562 (Pubitemid 39314961)
32. M.H. Shishehbor, S. Madhwal, and V. Rajagopal Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol Intv 2 2009 46 53
33. G. Ndrepepa, S. Braun, and A. Dibra Iron status and clinical outcome in patients with coronary artery disease after coronary stenting Nutr Metab Cardiovasc Dis 15 2005 418 425 [Epub 2005, Jul 1] (Pubitemid 43986477)
34. L.R. Zacharski, L. Mckernan, and M.E. Metzger Iron reduction for paroxysmal atrial fibrillation in haemophilia A Haemophilia 16 2010 726 730 [E-pub 2010, Mar 4]
35. I.A. Paraskevaidis, E.K. Iliodromitis, and D. Vlahakos Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance Eur Heart J 26 2005 263 270 (Pubitemid 40227432)
36. Video demonstration of breakfast cereal adulterated with iron filings used as an iron supplement Available at: http://www.youtube.com/watch?v= 5ahlawrQHeA 2011 Last accessed March 21, 2011
37. L. Mascitelli, F. Pezzetta, and M.R. Goldstein Is the beneficial antioxidant effect of olive oil mediated by interaction of its phenolic constituents and iron? Arch Med Res 41 2010 295 296
38. L. Mascitelli, and M.R. Goldstein Inhibition of iron absorption by polyphenols as an anti-cancer mechanism QJM 104 2011 459 461
39. J. Beard Dietary iron intakes and elevated iron stores in the elderly: is it time to abandon the set-point hypothesis of regulation of iron absorption? Am J Clin Nutr 76 2002 1189 1190 (Pubitemid 35416550)